Join our CEO Jean-Philippe Vert on the RARECast podcast to discover how we are using foundation models to rewrite rare disease R&D and repurpose existing drugs .

In this deep-dive episode of the Empowered Paient Podcast, Jean-Philippe explains why understanding biology across all scales—from molecules to organs—is the key to unlocking the next generation of precision medicine.

At Slush 2024, our Founding COO Mathilda Strom took the stage to unveil how we at Bioptimus are building the world's first multiscale, multimodal foundation model for biology.

Join our Founding COO Mathilda Strom on the Startup Scaleup People podcast to explore how we are using AI to fix the 90% clinical trial failure rate. In this episode, Mathilda shares insights from her 20-year career in scaling high-impact ventures and explains why Bioptimus is a different kind of deep-tech challenge.

Discover how we at Bioptimus track and refine our foundation models for biology, to make them learn the language of life so they can help you accelerate drug discovery and compress development timelines.

Mathilda Strom, the Founding COO at Bioptimus, shares her journey from building startups across Africa, Asia, and Latin America to helping shape one of the most ambitious AI and biology projects on the planet.

Discover how AI foundation models are revolutionising biology and drug discovery. Jean-Philippe Vert explores the future of multiscale virtual cells.

Slush is a founder-focused annual event delivering actionable company-building advice while bringing together the who’s who in startups and tech.

Can AI become a universal simulator of biology, helping predict disease, improve drug success rates, and reshape how medicine is developed? A thoughtful conversation on AI, biology, and the future of medicine. From lessons learned in big tech to what it takes to build enduring platforms in TechBio, this is a considered discussion for anyone interested in where scientific discovery is heading.